Evidence map›Paper›PMID 33312133›Full record

ArticleFrontiers in psychiatry2020

Basic Symptoms Are Associated With Age in Patients With a Clinical High-Risk State for Psychosis: Results From the PRONIA Study.

Helene Walger, Linda A Antonucci, Alessandro Pigoni, Rachel Upthegrove, Raimo K R Salokangas, Rebekka Lencer, Katharine Chisholm, Anita Riecher-Rössler, Theresa Haidl, Eva Meisenzahl and 14 more

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Basic symptoms of psychosis-from historical foundations to current evidence.Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The impact of visual dysfunctions in recent-onset psychosis and clinical high-risk state for psychosis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Helene WalgerDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
Linda A AntonucciDepartment of Education, Psychology, Communication, University of Bari Aldo Moro, Bari, Italy.
Alessandro PigoniDepartment of Neurosciences and Mental Health, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Foundation Major Hospital Polyclinic, University of Milan, Milan, Italy.
Rachel UpthegroveInstitute for Mental Health, University of Birmingham, Birmingham, United Kingdom.
Raimo K R SalokangasDepartment of Psychiatry, Medical Faculty, University of Turku, Turku, Finland.
Rebekka LencerDepartment of Psychiatry and Psychotherapy, and Otto Creutzfeldt Center for Cognitive and Behavioral Neuroscience, University of Muenster, Muenster, Germany.
Katharine ChisholmInstitute for Mental Health, University of Birmingham, Birmingham, United Kingdom.
Anita Riecher-RösslerDepartment of Psychiatry (Psychiatric University Hospital, UPK), University of Basel, Basel, Switzerland.
Theresa HaidlDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Eva MeisenzahlDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Marlene RosenDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Stephan RuhrmannDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Joseph KambeitzDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Lana Kambeitz-IlankovicDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Peter FalkaiDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
Anne RuefDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
Jarmo HietalaDepartment of Psychiatry, Medical Faculty, University of Turku, Turku, Finland.
Christos PantelisMelbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Carlton, VIC, Australia.
Stephen J WoodInstitute for Mental Health, University of Birmingham, Birmingham, United Kingdom.
Paolo BrambillaDepartment of Neurosciences and Mental Health, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Foundation Major Hospital Polyclinic, University of Milan, Milan, Italy.
Alessandro BertolinoGroup of Psychiatric Neuroscience, Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
Stefan BorgwardtDepartment of Psychiatry (Psychiatric University Hospital, UPK), University of Basel, Basel, Switzerland.
Nikolaos KoutsoulerisDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
Frauke Schultze-LutterDepartment of Education, Psychology, Communication, University of Bari Aldo Moro, Bari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In community studies, both attenuated psychotic symptoms (APS) and basic symptoms (BS) were more frequent but less clinically relevant in children and adolescents compared to adults. In doing so, they displayed differential age thresholds that were around age 16 for APS, around age 18 for perceptive BS, and within the early twenties for cognitive BS. Only the age effect has previously been studied and replicated in clinical samples for APS. Thus, we examined the reported age effect on and age thresholds of 14 criteria-relevant BS in a patient sample at clinical-high risk of psychosis (

Indexed as

agebasic symptomsbrain maturationclinical high riskpsychosis

Identifiers

PMID33312133
PMCPMC7707000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.